• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型神经纤维瘤病(雷克林豪森病)。与同胞对照进行神经学和认知评估。

Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls.

作者信息

Eldridge R, Denckla M B, Bien E, Myers S, Kaiser-Kupfer M I, Pikus A, Schlesinger S L, Parry D M, Dambrosia J M, Zasloff M A

机构信息

Neuroepidemiology Branch National Institutes of Health, Bethseda, Md.

出版信息

Am J Dis Child. 1989 Jul;143(7):833-7.

PMID:2500844
Abstract

Neurologic and cognitive function in neurofibromatosis type 1 (NF1) were assessed in a controlled pilot study of 13 pairs of siblings aged 6 to 27 years. One subject in each pair was affected with NF1, and the other, the control subject, was unaffected. Subjects with evidence of focal central nervous system disease were excluded. The 13 subjects with NF1 had no excess of mental retardation, attention-deficit disorder, or specific learning disorders (using Wilcoxon's Signed Rank Test and McNemar's Test for Symmetry). These subjects, however, had significantly higher scores for subtle neurologic abnormalities (21 vs 6) and significantly lower full-scale IQ scores (94 vs 105) than their unaffected siblings. The IQ scores of the affected subjects were not clustered at the lower end of the scale but showed a slight downward shift in distribution compared with those of their siblings. In addition, a visual-spatial orientation deficit was present in eight of nine affected subjects so evaluated. The findings suggest that subjects with NF1 have a widespread alteration of the brain during development that manifests as one or more specific types of neuropsychologic deficits.

摘要

在一项针对13对年龄在6至27岁的兄弟姐妹的对照性初步研究中,对1型神经纤维瘤病(NF1)患者的神经和认知功能进行了评估。每对中的一名受试者患有NF1,另一名作为对照受试者未患病。排除有局灶性中枢神经系统疾病证据的受试者。13名患有NF1的受试者没有智力发育迟缓、注意力缺陷障碍或特定学习障碍(使用威尔科克森符号秩检验和麦克尼马尔对称性检验)。然而,这些受试者的轻微神经异常得分显著更高(21分对6分),全量表智商得分显著更低(94分对105分),高于其未患病的兄弟姐妹。患病受试者的智商得分并非集中在量表的低端,而是与他们的兄弟姐妹相比,分布略有向下偏移。此外,在接受评估的9名患病受试者中,有8名存在视觉空间定向缺陷。研究结果表明,患有NF1的受试者在发育过程中大脑存在广泛改变,表现为一种或多种特定类型的神经心理缺陷。

相似文献

1
Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls.1型神经纤维瘤病(雷克林豪森病)。与同胞对照进行神经学和认知评估。
Am J Dis Child. 1989 Jul;143(7):833-7.
2
Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings.1型神经纤维瘤病患者及其未患病同胞的认知功能。
Turk J Pediatr. 2009 Nov-Dec;51(6):565-71.
3
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.1型神经纤维瘤病患儿认知缺陷的性质和频率。
Neurology. 2005 Oct 11;65(7):1037-44. doi: 10.1212/01.wnl.0000179303.72345.ce.
4
Children and adolescents with neurofibromatosis 1: a behavioral phenotype.患有1型神经纤维瘤病的儿童和青少年:一种行为表型。
J Dev Behav Pediatr. 1996 Aug;17(4):229-39.
5
[Cognitive dysfunction and emotional disturbances in children with neurofibromatosis type one (Recklinghausen's disease). Review of the literature].[1型神经纤维瘤病(雷克林霍增氏病)患儿的认知功能障碍与情绪障碍。文献综述]
Psychiatr Pol. 2005 Mar-Apr;39(2):371-81.
6
Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.神经纤维瘤病 1 型成人的神经心理学特征与对照组比较。
J Intellect Disabil Res. 2013 Sep;57(9):874-86. doi: 10.1111/j.1365-2788.2012.01648.x. Epub 2012 Oct 24.
7
A mouse model for the learning and memory deficits associated with neurofibromatosis type I.一种与I型神经纤维瘤病相关的学习和记忆缺陷的小鼠模型。
Nat Genet. 1997 Mar;15(3):281-4. doi: 10.1038/ng0397-281.
8
Cognitive control in adolescents with neurofibromatosis type 1.1型神经纤维瘤病青少年的认知控制
Neuropsychology. 2009 Jan;23(1):50-60. doi: 10.1037/a0013927.
9
Cognitive development in Silver-Russell syndrome: a sibling-controlled study.Silver-Russell综合征的认知发展:一项同胞对照研究。
Dev Med Child Neurol. 2004 May;46(5):340-6.
10
Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.1型神经纤维瘤病患儿的学习障碍:亚型、认知特征及注意力缺陷多动障碍
Dev Med Child Neurol. 2006 Dec;48(12):973-7. doi: 10.1017/S0012162206002131.

引用本文的文献

1
A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.1 型神经纤维瘤病的智力、神经心理学和心理教育功能的系统评价和荟萃分析。
Am J Med Genet A. 2022 Aug;188(8):2277-2292. doi: 10.1002/ajmg.a.62773. Epub 2022 May 12.
2
Therapeutic Effects of Apamin as a Bee Venom Component for Non-Neoplastic Disease.蜂毒组分蜂毒肽治疗非肿瘤性疾病的疗效。
Toxins (Basel). 2020 Mar 19;12(3):195. doi: 10.3390/toxins12030195.
3
Skeletal muscle and motor deficits in Neurofibromatosis Type 1.
1型神经纤维瘤病中的骨骼肌和运动功能障碍
J Musculoskelet Neuronal Interact. 2015 Jun;15(2):161-70.
4
Neurodevelopmental and Cognitive Outcomes of Classical Homocystinuria: Experience from Qatar.经典型同型胱氨酸尿症的神经发育和认知结局:来自卡塔尔的经验。
JIMD Rep. 2015;21:89-95. doi: 10.1007/8904_2014_394. Epub 2015 Feb 25.
5
Understanding intellectual disability through RASopathies.通过RAS病理解智力残疾
J Physiol Paris. 2014 Sep-Dec;108(4-6):232-9. doi: 10.1016/j.jphysparis.2014.05.003. Epub 2014 May 21.
6
Cognitive and psychosocial phenotype of young children with neurofibromatosis-1.1型神经纤维瘤病幼儿的认知和心理社会表型
J Int Neuropsychol Soc. 2014 Jan;20(1):88-98. doi: 10.1017/S1355617713001227. Epub 2013 Nov 15.
7
Height assessments in children with neurofibromatosis type 1.1型神经纤维瘤病患儿的身高评估
J Child Neurol. 2013 Mar;28(3):303-7. doi: 10.1177/0883073812446310. Epub 2012 Jun 29.
8
Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.NF1 突变型小鼠纹状体多巴胺减少导致注意系统功能障碍。
Hum Mol Genet. 2010 Nov 15;19(22):4515-28. doi: 10.1093/hmg/ddq382. Epub 2010 Sep 7.
9
Neurocognitive dysfunction in children with neurofibromatosis type 1.1型神经纤维瘤病患儿的神经认知功能障碍
Curr Neurol Neurosci Rep. 2003 Mar;3(2):129-36. doi: 10.1007/s11910-003-0064-3.
10
A child with axillary freckling and café au lait spots.一名患有腋窝雀斑和牛奶咖啡斑的儿童。
CMAJ. 2002 Aug 6;167(3):282-3.